A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in Europe. The aim of this clinical trial was to evaluate the blood
glucose-lowering effect of NN1250 (insulin degludec/insulin 454) in subjects with type 2
diabetes.